nasal spray

MONTREAL and CHARLOTTE, N.C. — September 24, 2026 Milestone Pharmaceuticals Inc. announced that the Montreal Heart Institute has enrolled...

RAANANA, Israel — September 22, 2026 Polyrizon Ltd. announced enrollment of the first patient in its U.S. clinical study...

MELBOURNE, Australia — September 15, 2026 ENA Respiratory announced that the first participants have been dosed in Part B...

NASHVILLE, Tenn., August 6, 2026 Harrow Inc. announced it has entered into a definitive agreement to acquire the global...

RAANANA, Israel, July 2, 2026 Polyrizon Ltd. announced the successful completion of its NASARIX™ biocompatibility evaluation program, marking an...

San Diego, U.S. | April 15, 2026 ARS Pharmaceuticals has achieved a major regulatory milestone with Health Canada approval...